Presentation is loading. Please wait.

Presentation is loading. Please wait.

Comparison of the model incorporating daily dose to that incorporating Cmax. Comparison of the model incorporating daily dose to that incorporating Cmax.

Published byGlória Amado Carreiro Modified over 5 years ago

Similar presentations

Presentation on theme: "Comparison of the model incorporating daily dose to that incorporating Cmax. Comparison of the model incorporating daily dose to that incorporating Cmax."— Presentation transcript:

1 Comparison of the model incorporating daily dose to that incorporating Cmax.
Comparison of the model incorporating daily dose to that incorporating Cmax. (A) AUCs and 95% confidence intervals are depicted for the ROC curves derived from the models incorporating either daily dose or Cmax. The covariates are listed on the left, and the AUC for each one is shown on the right next to the 95% confidence interval (shown in brackets). (B) The ROC curves for the model incorporating daily dose and Cmax are indicated by red and blue lines, respectively. The 95% confidence intervals for the model incorporating daily dose and Cmax are shaded red or blue, respectively. Overlap between the confidence intervals for the two ROC curves appears in violet. Ashley R. Maiuri et al. J Pharmacol Exp Ther 2017;362: Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics

Download ppt "Comparison of the model incorporating daily dose to that incorporating Cmax. Comparison of the model incorporating daily dose to that incorporating Cmax."

Similar presentations

Representative 10-s EEG recordings from GAERS: during baseline (prior to injection of any drug) (i), following the i.c.v. injection of 4 μl of vehicle.

Representative 10-s EEG recordings from GAERS: during baseline (prior to injection of any drug) (i), following the i.c.v. injection of 4 μl of vehicle.
Copyright © 2007 American Medical Association. All rights reserved.

Copyright © 2007 American Medical Association. All rights reserved.
Additional file 2: Figure S1

Additional file 2: Figure S1
Htr-9 stimulates ICAM-1 gene expression in human ASM cells.

Htr-9 stimulates ICAM-1 gene expression in human ASM cells.
Dose-escalation patient response.

Dose-escalation patient response.
Zhi-hui Hou et al. JIMG 2012;5:

Zhi-hui Hou et al. JIMG 2012;5:
Nick Macklon, M.D., Ph.D.  Fertility and Sterility 

Nick Macklon, M.D., Ph.D.  Fertility and Sterility 
Evaluation of models incorporating the base covariates.

Evaluation of models incorporating the base covariates.
Figure 2 Circadian and ultradian fluctuations in corticosterone

Figure 2 Circadian and ultradian fluctuations in corticosterone
Representative radio-HPLC chromatograms for individual pooled methanolic fecal extracts for periods of maximum recovery of radioactivity after dosing of.

Representative radio-HPLC chromatograms for individual pooled methanolic fecal extracts for periods of maximum recovery of radioactivity after dosing of.
Total ion current-EMS chromatograms of SB939 and its metabolites after incubation in liver microsomal fractions for 60 min at a concentration of 50 μM.

Total ion current-EMS chromatograms of SB939 and its metabolites after incubation in liver microsomal fractions for 60 min at a concentration of 50 μM.
Structure of solid lipid nanoparticles (SLNs).

Structure of solid lipid nanoparticles (SLNs).
The three primary ADC components that determine which cells are targeted (antibody), how the drug is released (linker/trigger), and the mechanism of action.

The three primary ADC components that determine which cells are targeted (antibody), how the drug is released (linker/trigger), and the mechanism of action.
A Multicolor FISH Assay Does Not Detect DUP25 in Control Individuals or in Reported Positive Control Cells  Yanina Weiland, Jürgen Kraus, Michael R. Speicher 

A Multicolor FISH Assay Does Not Detect DUP25 in Control Individuals or in Reported Positive Control Cells  Yanina Weiland, Jürgen Kraus, Michael R. Speicher 
Heiko Lehrmann et al. JACEP 2018;j.jacep

Heiko Lehrmann et al. JACEP 2018;j.jacep
Fig. 2. Best model fits. Best model fits. Illustration of the best model fits for the (A) basic, (B) continuous, and (C) cluster models. See Table 1 and.

Fig. 2. Best model fits. Best model fits. Illustration of the best model fits for the (A) basic, (B) continuous, and (C) cluster models. See Table 1 and.
Cytotoxic activities of polymer micelles containing CFZ in H460 (A) and select micelle formulations in RPMI-8226 (B) cell lines. Cytotoxic activities of.

Cytotoxic activities of polymer micelles containing CFZ in H460 (A) and select micelle formulations in RPMI-8226 (B) cell lines. Cytotoxic activities of.
Cytotoxic effects of PM1 and PM2 empty particle controls and coincubation of CFZ with empty particles tested in H460 (A) and RPMI-8226 (B) cells. Cytotoxic.

Cytotoxic effects of PM1 and PM2 empty particle controls and coincubation of CFZ with empty particles tested in H460 (A) and RPMI-8226 (B) cells. Cytotoxic.
Geometric mean concentration-time profiles of (A) racemic BUP, R-BUP, and S-BUP; (B) racemic OHBUP, RR-OHBUP, and SS-OHBUP; (C) racemic ERY, SR-ERYHBUP,

Geometric mean concentration-time profiles of (A) racemic BUP, R-BUP, and S-BUP; (B) racemic OHBUP, RR-OHBUP, and SS-OHBUP; (C) racemic ERY, SR-ERYHBUP,
The additive model assumes unspecific effects of equal size in both the placebo and drug arm or groups of studies or experiments. The additive model assumes.

The additive model assumes unspecific effects of equal size in both the placebo and drug arm or groups of studies or experiments. The additive model assumes.

Similar presentations

Ads by Google